The prominent role of serotonergic degeneration in apathy, anxiety and depression in<i>de novo</i>Parkinson’s disease

Audrey Maillet, Paul Krack, Eugénie Lhommée, +13

Brain

Psychotropic MedicationPsychopharmacologyNeuropsychiatryClinical NeuroscienceSocial Sciences +23

Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs

Audrey Maillet, Élise Météreau, Léon Tremblay, +10

Movement Disorders

How emotional pictures influence visuospatial binding in short-term memory in ageing and Alzheimer’s disease?

Céline Borg, N. Leroy, Émilie Favre, +2

Brain and Cognition

Cognitive ScienceAlzheimer's DiseaseEmotional PicturesBrain FunctionMemory Loss +12

Deep Brain Stimulation of the Subthalamic Nucleus, but not Dopaminergic Medication, Improves Proactive Inhibitory Control of Movement Initiation in Parkinson's Disease

Émilie Favre, Bénédicte Ballanger, Stéphane Thobois, +2

Neurotherapeutics

Deep Brain StimulationNeuroanatomyParkinson DiseaseMedicineNeuropharmacology +11

Exploration of verbal and non-verbal semantic knowledge and autobiographical memories starting from popular songs in Alzheimer's disease

Sandrine Basaglia-Pappas, M. Laterza, Céline Borg, +3

International Psychogeriatrics

Wait and you shall see: sexual delay discounting in hypersexual Parkinson’s disease

Romuald Girard, Ignacio Obeso, Stéphane Thobois, +8

Brain

NeuropsychologyBehavioral AddictionAffective NeuroscienceReduced DiscountingSexual Delay Discounting +24

Interaction of Noradrenergic Pharmacological Manipulation and Subthalamic Stimulation on Movement Initiation Control in Parkinson's Disease

Marion Albares, Stéphane Thobois, Émilie Favre, +5

Brain stimulation

Subthalamic StimulationNeurophysiologyMovement Initiation ControlParkinson DiseaseNoradrenergic Pharmacological Manipulation +13

An implicit and reliable neural measure quantifying impaired visual coding of facial expression: evidence from the 22q11.2 deletion syndrome

Arnaud Leleu, Émilie Favre, Alexandre Yailian, +6

Translational Psychiatry

Social cognition in Wilson’s disease: A new phenotype?

Élodie Peyroux, Santaella Nelly, Emmanuel Broussolle, +6

PLoS ONE

NeuropsychologyNew PhenotypeAffective NeuroscienceNeuropsychiatrySocial Impairment +17

Computer-based cognitive remediation program for the treatment of behavioral problems in children with intellectual disability: the «COGNITUS &amp; MOI» study protocol for a randomized controlled trial

Émilie Favre, Élodie Peyroux, Marie-Noëlle Babinet, +2

BMC Psychiatry